Medidata partners with Circuit Clinical to strengthen clinical trial capabilities
pharmafile | January 27, 2022 | News story | Business Services |
Medidata has announced a partnership with Circuit Clinical to strengthen its decentralised clinical trial (DCT) capabilities. Circuit Clinical has created a network representing over 90 doctors, across 30+ site locations, and a nationally accredited cancer center with a database of over 2.5 million participants who may qualify for clinical trials.
With Medidata’s strategic investment in Circuit Clinical’s $27 million Series C funding, Circuit Clinical will expand its Decentralised Clinical Trial (DC) network to 500 physician investigators and 15 million patients, and help to bring clinical research as a care option to more people in need.
Circuit Clinical’s offering spans 10 therapeutic areas, including cardiovascular disease, diabetes, women’s health, kidney disease, digestive diseases, COVID-19, and others. Individuals in Circuit Clinical’s participating healthcare systems will be invited to join myMedidata Clinical Trial Patient Registries, providing improved awareness of and access to clinical trial opportunities and continuous support.
“This partnership represents a category-defining approach to providing sponsors and patients with a unified platform for all DCT needs and will improve patient access, inclusion, and experience in clinical trials while accelerating timelines for sponsors and CROs,” said Kelly McKee, vice president of patient registries and recruitment at Medidata. “Working with Circuit Clinical further extends Medidata’s capabilities in the DCT space by collaborating with a market-leading integrated research organisation focused on optimising retention, decreasing patient burden, and identifying and creating top-performing sites.”
“We look forward to breaking new ground with Medidata in the emerging DCT marketplace and making a real difference in the lives of patients,” said Irfan Khan, MD, CEO of Circuit Clinical. “The combined capabilities of Circuit Clinical and Medidata’s software solutions will further the ability to deliver hybrid or fully decentralised trials through Circuit Clinical’s Network Health Systems and patient engagement capabilities. We look forward to welcoming Medidata to our Board of Directors as an observer.”
Lina Adams
